SIGA Technologies, Inc.

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.

صناعة

Drug Manufacturers - Specialty & Generic

قطاع

Healthcare

المقر الرئيسي

US

المدير التنفيذي

Diem Nguyen

المدرجة منذ ذلك الحين

10 سبتمبر 1997

موظفين

49

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.

صناعة

Drug Manufacturers - Specialty & Generic

قطاع

Healthcare

المقر الرئيسي

US

المدير التنفيذي

Diem Nguyen

المدرجة منذ ذلك الحين

10 سبتمبر 1997

موظفين

49